Ryosuke Negoro
Impact in
- Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Pluripotent Stem Cells Research 6
- Renal and related cancers 3
- CRISPR and Genetic Engineering 3
-
- 3D Printing in Biomedical Research 7
- Co-authors
- Kazuo Takayama (15 shared papers)Hiroyuki Mizuguchi (9 shared papers)Fuminori Sakurai (4 shared papers)Masashi Tachibana (2 shared papers)Kazuo Harada (3 shared papers)Kazumasa Hirata (3 shared papers)Takuya Fujita (9 shared papers)Sayaka Deguchi (9 shared papers)
In The Last Decade
Ryosuke Negoro
22 papers receiving 304 citations
Peers
Comparison fields: 5 of 66
- Pharmacology 56
- Pharmaceutical Science 23
- Oncology 97
- Biomedical Engineering 116
- Transplantation 6
Countries citing papers authored by Ryosuke Negoro
This map shows the geographic impact of Ryosuke Negoro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryosuke Negoro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryosuke Negoro more than expected).
Fields of papers citing papers by Ryosuke Negoro
This network shows the impact of papers produced by Ryosuke Negoro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryosuke Negoro. The network helps show where Ryosuke Negoro may publish in the future.
Co-authors
The 25 scholars most cited alongside Ryosuke Negoro, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 48 | |
| 2 | 2015 | 47 | |
| 3 | 2016 | 42 | |
| 4 | 2019 | 40 | |
| 5 | 2020 | 15 | |
| 6 | 2021 | 15 | |
| 7 | 2023 | 12 | |
| 8 | 2019 | 12 | |
| 9 | 2021 | 10 | |
| 10 | 2022 | 9 | |
| 11 | 2021 | 9 | |
| 12 | 2024 | 8 | |
| 13 | 2021 | 7 | |
| 14 | 2023 | 6 | |
| 15 | 2020 | 6 | |
| 16 | 2020 | 6 | |
| 17 | 2024 | 5 | |
| 18 | 2024 | 4 | |
| 19 | 2023 | 3 | |
| 20 | 2021 | 2 |
About Ryosuke Negoro
Ryosuke Negoro is a scholar working on Molecular Biology, Biomedical Engineering, Oncology, Pharmacology and Surgery, having authored 23 papers that have together received 309 indexed citations. Recurring topics across this work include 3D Printing in Biomedical Research (7 papers), Pluripotent Stem Cells Research (6 papers), Pharmacogenetics and Drug Metabolism (5 papers), Pancreatic function and diabetes (4 papers), Renal and related cancers (3 papers), Cancer Cells and Metastasis (3 papers), CRISPR and Genetic Engineering (3 papers) and Drug Transport and Resistance Mechanisms (3 papers). The work is most often cited by research in Pharmacology (56 citations), Pharmaceutical Science (23 citations), Oncology (97 citations), Biomedical Engineering (116 citations) and Transplantation (6 citations). Ryosuke Negoro has collaborated with scholars based in Japan and Ireland. Frequent co-authors include Kazuo Takayama, Hiroyuki Mizuguchi, Fuminori Sakurai, Masashi Tachibana, Kazuo Harada, Kazumasa Hirata, Takuya Fujita, Sayaka Deguchi, Yasuhito Nagamoto and Tatsuya Ozawa. Their work appears in journals such as Scientific Reports, Drug Metabolism and Pharmacokinetics, ACS Biomaterials Science & Engineering, Molecular Therapy — Methods & Clinical Development and Biological and Pharmaceutical Bulletin.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.